Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. This brief summarizes the main findings of the longer research publication, HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues.

Corporate author(s): PATH, International AIDS Vaccine Initiative

Publication date: December 2007

Available materials

English

Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues

(Located at www.rho.org)

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA